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Abstract
Background: When conventional high-volume, low-pressure cuffs of endotracheal tubes (ETTs) are inflated, channel
formation due to folds in the cuff wall can occur. These channels facilitate microaspiration of subglottic secretions,
which is the main pathogenic mechanism leading to intubation-related pneumonia. Ultrathin polyurethane
(PU)-cuffed ETTs are developed to minimize channel formation in the cuff wall and therefore the risk of
microaspiration and respiratory infections.
Methods: We systematically reviewed the available literature for laboratory and clinical studies comparing fluid
leakage or microaspiration and/or rates of respiratory infections between ETTs with polyvinyl chloride (PVC)
cuffs and ETTs with PU cuffs.
Results: The literature search revealed nine in vitro experiments, one in vivo (animal) experiment, and five
clinical studies. Among the 9 in vitro studies, 10 types of PU-cuffed ETTs were compared with 17 types of
PVC-cuffed tubes, accounting for 67 vs. 108 experiments with 36 PU-cuffed tubes and 42 PVC-cuffed tubes,
respectively. Among the clinical studies, three randomized controlled trials (RCTs) were identified that involved
708 patients. In this review, we provide evidence that PU cuffs protect more efficiently than PVC cuffs against
fluid leakage or microaspiration. All studies with leakage and/or microaspiration as the primary outcome
demonstrated significantly less leakage (eight in vitro and two clinical studies) or at least a tendency toward
more efficient sealing (one in vivo animal experiment). In particular, high-risk patients intubated for shorter
periods may benefit from the more effective sealing capacity afforded by PU cuffs. For example, cardiac surgery
patients experienced a lower risk of early postoperative pneumonia in one RCT. The evidence that PU-cuffed
tubes prevent ventilator-associated pneumonia (VAP) is less robust, probably because microaspiration is
postponed rather than eliminated. One RCT demonstrated no difference in VAP risk between patients
intubated with either PU-cuffed or PVC-cuffed tubes, and one before-after trial demonstrated a favorable
reduction in VAP rates following the introduction of PU-cuffed tubes.
Conclusions: Current evidence can support the use of PU-cuffed ETTs in high-risk surgical patients, while there
is only very limited evidence that PU cuffs prevent pneumonia in patients ventilated for prolonged periods.
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Background
Intubation-related pneumonia, including ventilator-associated
pneumonia (VAP) or early postoperative pneumonia,
remains a feared complication in the acute healthcare
setting. Despite a plethora of preventive measures and
growing attention to care bundle initiatives for patients
at risk, the average occurrence rate of VAP among in-
tensive care unit (ICU) patients intubated for at least
2 days ranges from 10 % to 20 % [1–5]. This is particu-
larly worrisome, given the substantial clinical and eco-
nomic burden of this infectious complication [6]. With
an excess length of ICU stay of 5–7 days, there exists
an important cost-saving potential [3].
The main pathogenic mechanism of intubation-related
pneumonia is bacterial translocation from the stomach
and/or oropharynx to the lower respiratory tract. Within
a few hours following endotracheal intubation, pathogenic
microorganisms colonize the oropharyngeal mucosa,
dental plaque, stomach, and sinuses. As such, microbio-
logically contaminated subglottic secretions accumulate
above the cuff of the endotracheal tube (ETT). While
the purpose of the cuff is to seal the extraluminal air-
way, its effectiveness is not flawless. When conventional
high-volume, low-pressure (HVLP) cuffs are inflated,
channel formation due to folds in the cuff wall can occur.
These channels facilitate microaspiration of subglottic se-
cretions, even when the cuff pressure (Pcuff ) is adequate
(20–30 cmH2O) [7].
Ultrathin polyurethane (PU) cuffs have been developed
to minimize the channel size within the folds of an in-
flated cuff. While the cuff membrane thickness of
conventional polyvinyl chloride (PVC) cuffs is about
50–70 μm, the cuff wall thickness of PU cuffs ranges
from 7 to 10 μm [8]. Therefore, the intention of these
PU-cuffed ETTs is that the relatively smaller cuff channels
will minimize microaspiration of subglottic secretions and
thus the risk for intubation-related pneumonia. The pur-
pose of this study was to systematically review the evidence,
including that from laboratory and clinical investigations,
concerning the effectiveness of PU-cuffed ETTs to
minimize fluid leakage (microaspiration) and intubation-
related pneumonia compared with conventional PVC-
cuffed ETTs.
Methods
Search strategy
The PubMed, EMBASE, and Web of Science databases
were each systematically searched using the following
key terms: “endotracheal” OR “tracheal,” “poly-urethane”
OR “polyurethane,” AND “cuff.” Additionally, the snow-
ball method was used to detect potentially eligible studies.
The literature searches were performed on 7 December
2015 without time or language restriction. No predefined
review protocol was registered.
Study selection
Eligible studies included nonclinically (i.e., laboratory) or
clinically controlled studies in which fluid leakage (either
laboratory or clinical studies) or intubation-related pneu-
monia (clinical studies) was compared between PU- and
PVC-cuffed ETTs. Search results were screened by title
and abstract. Selected papers underwent a full-text assess-
ment, and eligibility issues were resolved between authors.
Reference inclusion and exclusion criteria for this review
are described in Table 1.
Data extraction and quality assessment
Extracted data included study setting, design, and sample
size; implemented interventions; definitions; presence or
volume of fluid leakage; and rates of respiratory infections.
The methodological quality (i.e., risk of bias) of included
randomized controlled trials (RCTs) was assessed using
the Jadad quality scale, which assigns a score ranging from
0 to 5 points, with a score ≥3 indicating a high-quality
study [9]. Evaluation criteria in the Jadad scale assessment
include randomization, blinding, and accounting for all
study subjects. For non-RCTs, the risk of bias was
assessed using the Downs and Black tool [10]. This score
is based on 27 questions related to reporting of the data,
internal and external validity, and factors potentially
confounding internal validity. Summaries of the methodo-
logical evaluations of included RCTs and non-RCTs are
shown in Additional file 1.
Table 1 Literature selection criteria
Inclusion criteria
• Experimental and clinical studies
• Intervention arm with high-volume, low-pressure (HVLP) polyurethane
(PU)-cuffed endotracheal tube
• Control group with HVLP conventional polyvinyl chloride (PVC)-cuffed
endotracheal tube
• Studies evaluating either fluid leakage or intubation-related respiratory
infection (early-postoperative pneumonia, ventilator-associated
tracheobronchitis, ventilator-associated pneumonia)
• Article written in English or Dutch
Exclusion criteria
• Descriptive studies
• Studies without a control group
• Evidence of confounders in one of the study arms, such as the use
of additional measures to reduce the risk of microaspiration (e.g.,
subglottic secretions drainage, taper-shaped cuff, gel lubrication of
the cuff, positive end-expiratory pressure) or use of measures to
prevent pneumonia (e.g., hand hygiene promotion, head-of-bed
elevation) in only one of the study arms. Differences in cuff shape
other than conical (taper-shaped) were not considered an exclusion
criterion. As such, comparisons of cylindrical PU cuff vs. globular PVC
cuffs were accepted.
• Not original research (reviews, systematic reviews, meta-analysis,
editorials, letters)
• No full text available
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According to the objective of this review, for studies
evaluating multiple types of ETTs, only comparisons of
PU-cuffed ETTs with conventional PVC-cuffed tubes
were selected (see also Table 1 for inclusion and exclusion
criteria). If necessary, statistical analyses were performed
on reported data in the original articles (Fisher’s exact test
for comparison of leakage and/or pneumonia rates).
Where necessary, the authors of the original studies were
contacted to provide additional information.
Results and discussion
The search strategy yielded 205 records. Following title,
abstract, and full-text assessments, 14 publications were
included for final evaluation (Fig. 1). The studies included
nine different in vitro experiments (Table 2), one in vivo
experiment (Table 2), and five clinical studies (Table 3).
In vitro studies
Among the 9 in vitro studies, 10 types of PU-cuffed
ETTs were compared with 17 types of PVC-cuffed tubes,
accounting for 67 vs. 108 experiments with 36 PU-cuffed
tubes and 42 PVC-cuffed tubes, respectively (Table 2).
The results of these studies were generally in favor of
PU-cuffed tubes, primarily because they demonstrated
no or, compared with PVC-cuffed tubes, less fluid leak-
age. Several aspects of the experimental setup should
be considered, including shape and elasticity of the tra-
chea model, positioning of the tube, room temperature,
gel lubrication of the cuff, Pcuff, viscosity of the fluid,
ventilatory simulation and positive end-expiratory pres-
sure (PEEP), additional cuff characteristics, and duration
of the leakage observation. These aspects are summarized
in Table 2.
Gel lubrication of ETT cuffs reduces the risk of micro-
aspiration by plugging channels formed in the cuff wall.
In one study, the sealing capacity of cuffs was tested
with and without gel lubrication. Improved sealing was
observed in all tested tubes except one PVC-cuffed tube
[8]. On the one hand, an argument in favor of not using
lubricated cuffs is that in such experiments the sole po-
tential of cuff material to avoid leakage was evaluated.
On the other hand, gel lubrication is standard in daily
Fig. 1 Flowchart of the literature search
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Table 2 Summary of laboratory studies
Author, year Materials tested Experimental settings Pcuff Fluid and leakage
measurement
Experiment
repetition
Main results
In vitro studies
Dullenkopf,
2003 [8]
• 1 PU-cuffed ETT (MICROCUFF
HVLP ICU; Microcuff GmbH,
Heidelberg, Germany)
• 4 PVC-cuffed ETTs (Portex
Profile Soft Seal, SIMS Portex
Ltd., Hythe, UK; Rüschelit Super
Safety Clear, Rüsch GmbH,
Kernen, Germany; Mallinckrodt
Hi-Lo, Mallinckrodt Medical,
Athlone, Ireland; Sheridan/CF,
Hudson Respiratory Care,
Temecula, USA)
• ID all ETTs 7.5 mm
• Vertical PVC trachea model
(ID 20 mm)
• Unlubricated and lubricated
cuffs
• No ventilatory simulation
• 10, 15, 20, 25,
30, 60 cmH2O
• Controlled by
manometer
• Colored water (5 ml)
• Amount of leaked
fluid passed through
tube cuff within 5,
10, and 60 minutes
4 repetitions of
2 tubes of each
brand
• Fluid leakage occurred
in all PVC cuffs at Pcuff
10–60 cmH2O. In the
PU cuff, leakage was
recorded only at Pcuff
10 cmH2O (<5 minutes)
and at Pcuff 15 cmH2O
(<60 minutes)
• PU cuffs sealed significantly
better at conventional
Pcuff (20–30 cmH2O)
than with all types of PVC
cuffs; while no leak was
observed in PU cuffs,
>90 % of the test fluid
(>4.5 ml) passed through
cuff in all PVC cuffs
Lucangelo,
2008 [14]
• PU-cuffed ETT (Mallinckrodt
SealGuard, Mallinckrodt
Medical, Cornamady, Anthlone
County, Ireland)
• PVC-cuffed ETT (Mallinckrodt
Hi-Lo, Mallinckrodt Medical,
Cornamady, Anthione County,
Ireland)
• ID all ETTs 7.5 mm
• Room temperature
• Vertical Pyrex cylindertrachea
model, ID 25 mm
• Unlubricated cuffs
• 5-, 7.5-, and 10-cm PEP
randomly applied
• PEP removed after 30 minutes
• Experiment lasted 1 h
• 30 cmH2O
• Controlled
by aneroid
manometer
• Evans blue (1 ml)
diluted with normal
saline (1 ml)
Triplicate
experiments
with new ETTs
• 10 minutes after PEP
removal (40 minutes after
Evans blue dye application
on top of cuffs), all liquid
had passed through PVC
cuffs
• No leakage in PU cuffs
Dave, 2010
[24]
• PU-cuffed ETTs (standard
SealGuard, Covidien, Athlone,
Ireland;
MICROCUFF, Kimberley Clark,
Zaventem, Belgium)
• 3 PVC-cuffed ETT
(Hi-Lo, Covidien, Athlone,
Ireland; Portex
Profile Soft Seal, SIMS Portex Ltd.,
Hythe, UK; Rüschelit
Super Safety Clear, Rüsch GmbH,
Kernen, Germany) ID all
ETTs 7.5 mm
• Room temperature
• Artificial PVC trachea model
with variable ID 16, 20, 22 mm
• Unlubricated cuffs
• No ventilatory simulation,
no PEEP
• 25 cmH2O
• Controlled by
digital automated
manometer
• Clear water (5 ml)
• Leakage measured at
5 minutes and
60 minutes
8 tubes tested of
each ETT type
PVC cuffs leaked considerably
more than PU cuffs
• At 5 minutes: - ID 16 and
20 mm: 0.03–1.62 ml (PU) vs.
4.27–4.67 ml (PVC) - ID
22 mm: 0–4.85 ml (PU) vs.
4.65–4.71 ml (PVC)
• At 60 minutes: - ID 16
and 20 mm: 0.90–4.58 ml
(PU) vs. 4.61–4.69 ml (PVC)
- ID 22 mm: 0–4.85 ml (PU)
vs. 4.65–4.75 ml (PVC)
Dave, 2011
[13]
• PU-cuffed ETT (SealGuard,
Covidien, Athlone, Ireland)
• PVC-cuffed ETT (Hi-Lo,
Covidien, Athlone, Ireland) ID
all ETTs 5 mm
• Vertical artificial PVC trachea
model, ID 22 mm
• Unlubricated cuffs
• Test lung attached to trachea
model
• Pressure-controlled ventilation
with PIP 15, 20, 25 cmH2O
• 25 and 50 cmH2O
• Controlled by
digital automated
manometer
• Clear water (10 ml) 4 tubes tested of
each ETT type
PU cuffs leaked less (range
0–0.12 ml) than PVC cuffs
(range 0.05–6.28 ml) at all
Pcuff levels (p < 0.001) and
at all negative suction
pressures tested (p < 0.001)
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Table 2 Summary of laboratory studies (Continued)
• PEEP 5 and 10 cmH2O
• Closed tracheal suction system
attached with variable suction
pressure (-20000 or -30000 Pa)
during 5, 10, 15, and 20 seconds
Kolobow,
2011 [27]
• 2 PU-cuffed ETTs (prototype
tube with Lycra PU cuff,
MICROCUFF, Kimberly-Clark,
Kimberly-Clark Health Care,
Roswell, Georgia, USA)
• PVC-cuffed ETT (Hi-Lo,
Mallinckrodt/Covidien, Boulder,
Colorado, USA) ID all ETTs 8 mm
• Vertical acrylic tube trachea
model, ID 20 mm
• Cuffs not lubricated
• No ventilatory simulation,
no PEEP
• 20 cmH2O
• Controlled by
aneroid manometer
• Methylene blue-colored
water (15 ml)
• Leak time observation 24 h
• Leakage expressed
as milliliters per hour
6 tubes tested of
each ETT type
• No leakage in Lycra PU
prototype ETT
• The other PU cuff
(MICROCUFF) allowed
less leakage (1.2 ±
0.4 ml/h) than PVC
cuff (1.2 ± 1.3 ml/h)
(p < 0.001)
Ouanes,
2011 [25]
• PU-cuffed ETTs (MICROCUFF,
Kimberly-Clark, Zaventem,
Belgium)
• PVC-cuffed ETT (Rüschelit Super
Safety Murphy, Rüsch GmbH,
Kernen, Germany) ID ETTs 7.5
and 8 mm
• Vertical artificial Plexiglas
trachea model, ID 18 mm
• Cuffs not lubricated
• Ventilatory settings
10 cmH2O PSV driven by
active inspiration with
trigger sensitivity at
2 L/minute and respiratory
rate at 20 breaths/minute.
Three effort intensities
(occlusion pressure at
0.1 second): low = 2 cmH2O,
moderate = 5 cmH2O, and
high = 10 cmH2O
• Experiments performed with
PEEP 0 and 5 cmH2O
• 30 cmH2O
• Controlled by
manual
manometer every 3
h
• Methylene blue (1 ml)
diluted with 4 ml normal
saline
• Leak time observation 1 h
• Leakage expressed as
milliliters per hour
3 tubes tested of
each ETT type
At all inspiratory levels
tested, significantly less
leakage occurred with PU
cuffs: mean 0.5 (SD 0.5)
ml/h vs. 36.8 (SD 31.6)
ml/h (p < 0.001)
Zanella,
2011 [15]
• PU-cuffed ETTs (MICROCUFF,
Kimberly-Clark, GA, USA)
• 3 PVC-cuffed ETT (Mallinckrodt
Hi-Lo, Mallinckrodt, NY, USA;
Mallinckrodt High-Contour,
Kimberly-Clark, Zaventem,
Belgium; Portex Ivory, Smiths
Medical, UK) ID all ETTs 8 mm
• Vertical PVC cylinder as trachea
model, ID 20 mm
• Cuffs not lubricated
• Ventilatory settings: CPAP
simulation with 4 levels of
PEEP randomly applied (0, 5,
10, and 15 cmH2O)
• 30 cmH2O
• Continuously
controlled by
water seal valve
providing
continuous
positive pressure
into pilot balloon
• Methylene blue-dyed
water added above the cuff to
make water column
10 cm
• Leak time camera
observation 24 h with
picture taken every
60 seconds
• Leakage expressed as
water column above
cuff (cm)
• Leakage detected by
blinded observer
5 tubes tested
of each ETT type,
at PEEP
5–15 cmH2O
5 new ETTs tested
at PEEP 0
Leakage observed after 24 h:
• PU cuff: - No leakage at
PEEP levels 5, 10, and
15 cmH2O - Minor leak
without PEEP (about 2 cm)
• 3 types of PVC cuffs: -No
leak at PEEP 15 cmH2O
- Minor leak at PEEP
10 cmH2O (about 2 cm)
- Major leak at PEEP
5 cmH2O (>8 cm)
- Maximum leak without
PEEP (10 cm)
Li Bassi,
2013 [11]
• 8 HVLP ETTs with various cuff
characteristics, among which
were: PU-cuffed ETT
• Artificial trachea model (ID
18, 20, and 22 mm) oriented
30 degrees above horizontal
• 15, 20, 25,
30 cmH2O
• Oropharyngeal
secretion simulant
3 tubes tested of
each ETT type
PU cuffs leaked substantially
less than PVC cuffs:
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Table 2 Summary of laboratory studies (Continued)
(Kimvent MICROCUFF, Kimberly
-Clark Health Care, Roswell, GA,
USA) PVC-cuffed ETTs (Rüschelit
Safety Clear Plus, Teleflex,
Limerick, PA, USA; Hi-Lo,
Covidien-Nellcore and Puritan
Bennett, Boulder, CO, USA)
• ID 7, 7.5, 8 mm
• Cuffs not lubricated
• No ventilatory simulation
• Short-term fluid sealing capacity
(1 h): 3 ETT IDs at 4 Pcuff levels
• Long-term fluid sealing capacity
(24 h) with 4 best-performing ETTs
at 1 h; experiment performed
with 7.5 mm ID ETTs and Pcuff
30 cmH2O
• Measurement: multivariate
analysis in which leakage rate
was evaluated considering
several other cuff characteristics:
Pcuff, cuff OD, cuff length,
PU cuff, taper-shaped cuff, ratio
cuff OD/trachea model ID, ratio
cuff OD/cuff length, cuff
compliance, and trachea
model ID
• Controlled
by automated
manometer
(viscosity 3 cP at shear
rate 75/second)
• Leakage recorded as
milliliters per hour
• Leak time observation
1 h and 24 h
• Short-term mean fluid
leakage rates (1 h):
- PU cuff (MICROCUFF):
0.09 ± 0.06 ml/h - PVC cuff
(Rüschelit): 4.46 ± 3.47 ml/h
- PVC cuff (Mallinckrodt Hi-Lo):
2.24 ± 1.93 ml/h
• Long-term mean fluid leakage
rates (24 h): - PU cuff
(MICROCUFF): 0.69 ± 0.36 ml/h
- PVC cuff (Mallinckrodt Hi-Lo):
114.74 ± 16.79 ml/h
• In multivariate analysis
(considering 8 types of ETTs
with various cuff characteristics),
internal Pcuff, cuff OD, and cuff
length were independently
associated with lower leakage
rates; cuff material did not
reach statistical significance in
this model
Lau, 2014
[23]
• PU-cuffed ETTs (Kimvent
MICROCUFF, Kimberly-Clark
Health Care, US)
• PVC-cuffed ETT (Portex, Smiths
Medical International Ltd., UK)
ID all ETTs 8 mm
• Silicone cylinder trachea
model (ID 20 mm)
oriented 35 degrees above
horizontal
• Cuffs not lubricated
• Ventilatory settings: 5
simulated mechanical
ventilation scenarios,
including different PEEP
levels and disconnection with
and without spontaneous
breathing effort. Each scenario
was tested under 3 Pcuff levels
and then repeated with
application of continuous
suction force (−200 cmH2O
for 3 minutes)
• 10, 20, 30 cmH2O
• Maintained by
automated
device
• Clear water (20 ml)
• Leakage observation
time 20 minutes.
• Leakage was video-
recorded and expressed
as cumulative amount
of leakage (ml)
2 ETTs of each
type, and each
ETT tested 4
times (8
measurements
for each ETT per
scenario and
Pcuff)
PU cuffs consistently
demonstrated best protection
against fluid leakage; clinical
situations associated with
greater leakage were
mechanical ventilation
without PEEP, circuit
disconnection with
spontaneous breathing,
application of suction, and
low Pcuff (10 cmH2O)
In vivo study
Li Bassi,
2015 [26]
• PU-cuffed ETTs (KimVent
MICROCUFF, Halyard Health,
USA)
• Large White-Landrace pigs
(37.3 ± 3.6 kg) randomized
to be intubated with either
of the test ETTs
• 28 cmH2O
• Maintained by
automated
device
• Methylene blue (2 ml)
and phosphate-buffered
solution (3 ml) with
1.5 μl of 2.0-μm Invitrogen
1 ETT per animal • Methylene blue was never
found in tracheal secretions
• Percentage of aspirated
microspheres was not
Blot
et
al.CriticalCare
 (2016) 20:203 
Page
6
of
13
Table 2 Summary of laboratory studies (Continued)
• PVC-cuffed ETT (Rüschelit
Safety Clear Plus, Teleflex
Incorporated, Limerick, PA, USA)
ID ETTs not reported
• 5 pigs in PU group
• 4 pigs in PVC group
• Intubated, ventilated, and
anesthetized for 76 h
• After 52 and 73 h, pigs
were placed in prone, bed
oriented 30 degrees above
horizontal, and PEEP
reduced to 0
fluorescent microspheres
(Life Technologies, Carlsbad,
CA, USA)
• 1 h from instillation, leakage
estimated by presence of
methylene blue and
quantification of microspheres
in tracheal secretions quantified
by calculating percentage of
recovered microspheres per
gram of tracheal secretions per
total amount of instilled
microspheres
significantly lower with PU
cuffs (0.06 ± 0.05 %) than
with PVC cuffs (0.12 ±
0.06 %)
Abbreviations: ICU intensive care unit, PEP positive expiratory pressure, PSV pressure support ventilation, PU polyurethane, PVC polyvinyl chloride, ETT endotracheal tube, HVLP high volume-low pressure, ID internal
diameter, Pcuff cuff pressure, PEEP positive end-expiratory pressure, PIP peak inspiratory pressure, PEP positive expiratory pressure, CPAP continuous positive airway pressure, cP centipoise, OD outer diameter
Study arms or aspects of the experimental setting that have no relationship with the outcome of interest of this review are not included in the summary of the individual studies
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Table 3 Summary of clinical studies
Author, year Materials tested Study design Pcuff Outcomes Main results
Lucangelo,
2008 [14]
• PU-cuffed ETT, cylindrical
shape (Mallinckrodt
SealGuard, Mallinckrodt
Medical, Cornamady,
Anthlone County,
Ireland)
• PVC-cuffed ETT, spindle-
like shape
(Mallinckrodt Hi-Lo,
Mallinckrodt Medical,
Cornamady, Anthlone
County, Ireland)
• RCT
• 2 groups of 20 ICU patients
requiring immediate orotracheal
intubation and mechanical
ventilation because of
deterioration of consciousness
(GCS score ≤8)
• Ventilatory settings: VC
ventilation with VT 8–9 ml/kg
and respiratory rate to maintain
normocapnia, and PEEP
(5 cmH2O)
• 5 h postintubation, PEEP was
removed
• Oral and tracheal secretions
were not aspirated during
experiment
• 30 cmH2O • Controlled
with aneroid manometer
• Evans blue (1 ml) diluted
in normal saline (1 ml)
• Bronchoscopic evaluation
to detect blue dye in
trachea at 1 h and 5 h
postintubation (with PEEP)
and hourly thereafter until
12 h postintubation (without
PEEP)
• As soon as blue spot was
seen on trachea caudal to
ETT tip, experiment was
finished
• 5 h postintubation, leakage observed
in 2 patients in PVC group
• At 6th hour (1 h after PEEP removal),
leakage observed in all patients in
PVC group
• In the PU group, first leakage occurred
after 8 h; at end of experiment (12th hour),
fluid leakage absent in 3 patients
• Difference between the 2 groups
(log-rank test on Kaplan-Meier survival
curves) was statistically significant (p < 0.001)
Poelaert,
2008 [30]
• PU-cuffed ETT, cylindrical
shape (SealGuard,
Covidien, Mansfield,
Mass, USA)
• PVC-cuffed ETT, cylindrical
shape (standard
Mallinckrodt, Mallinckrodt
Inc. Hazelwood, Mo, USA)
• Female patients: ID 8 mm
• Male patients: ID 9 mm
• RCT, single-blind
• 2 groups of 67 patients
scheduled for cardiac surgery
• Intraoperative antibiotic
prophylaxis with cefazolin 2 g
3 times daily for 24 h
• 20–26 cmH2O
• Controlled immediately
after intubation, at closure
of sternum, on arrival at
ICU, and every 4 h during
postoperative course
• Early postoperative
pneumonia (until 7 days
postoperatively)
• Nosocomial pneumonia
was defined as all of the
following:
- New/evolving infiltrate
on chest x-ray
- Temperature > 38.2 °C
- Leukocytosis (>12000
cells/mm3)
- Presence of purulent
sputum/endotracheal
aspirate
- Increase in C-reactive
protein for 2 consecutive
postoperative days
- Deterioration in PaO2/FiO2
ratio ≥20 %
• Diagnosis: assessor blinded
• Rate of postoperative pneumonia in PU
group significantly lower than PVC
group (23 % vs. 42 %; p = 0.026)
• In multivariate regression analysis, use
of PU-cuffed ETTs appeared to be
protective for early postoperative
pneumonia (OR 0.31, 95 % CI 0.13–0.77)
Nseir, 2010
[40]
• PU-cuffed ETT, cylindrical
shape (MICROCUFF,
Kimberly-Clark, Zaventem,
Belgium)
• PVC-cuffed ETT, cylindrical
shape (Mallinckrodt Hi-Lo
Lanz, Mallinckrodt Medical,
Athlone, Ireland)
• Prospective, observational trial
in ICU patients
• PVC group (patients included in
first 6 months of study, n = 26);
PVC group (patients included
in second period of 6 months,
n = 22)
• Patients observed during 24 h
with continuous monitoring of
Pcuff
• 25 cmH2O
• Manually adjusted every
8 h
• Pepsin in tracheal secretions
(ng/ml) used as proxy for
microaspiration of gastric
contents
• Recorded 24 h postintubation
• No difference in Pcuff variation observed
between groups
• Pepsin levels lower among patients with
PU-cuffed ETTs (217 ± 126 ng/ml) than in
PVC group (408 ± 282 ng/ml)
• Pepsin levels >200 ng/ml more common
in PVC group (69 % vs. 27 %; p = 0.008)
• Pepsin levels >300 ng/ml more common
in PVC group (61 % vs. 22 %; p = 0.009)
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Table 3 Summary of clinical studies (Continued)
• After 24 h, tracheal suctioning
to obtain aspirate sample for
pepsin measurement
• Pepsin levels considered positive
at 200 ng/ml
Miller, 2011
[32]
• PU-cuffed ETT, cylindrical
shape (MICROCUFF, Kimberly-
Clark Corporation, Roswell,
GA, USA)
• PVC-cuffed ETT, cylindrical
shape (conventional type)
• Before-after study with interrupted
time-series analysis
• 1 hospital, 5 ICUs
• Retrospective comparison of
VAP rates in respective periods
• 1 year of observation with
PVC-cuffed tubes before
intervention
• 1 year of observation with
PU-cuffed ETTs
• 3 months postintervention
observation (return to
conventional PVC-cuffed
ETTs)
Not reported • VAP rates expressed per 1000
ventilation days
• VAP diagnosed on basis of
clinical or microbiologic criteria,
based on CDC’s National
Healthcare Safety Network
standard definition [29]
• Baseline year of observation (PVC-cuffed
ETT): 37 VAP episodes (5.3/1000
ventilation days)
• Intervention year (PU-cuffed ETT): 21 VAP
episodes (2.8/1000 ventilation days)
(p = 0.0138)
• After return to PVC-cuffed ETTs, 6
episodes in 3 months (3.5/1000
ventilation days)
• Incidence risk ratio of VAP during
intervention year 0.57 (95 % CI 0.34–0.96)
Philippart,
2015 [31]
• PU-cuffed ETT, cylindrical
shape (MICROCUFF, Kimberly-Clark,
Irving, Tx, USA)
• PVC-cuffed ETT, cylindrical
shape (Hi-Lo, Covidien, Dublin,
Ireland)
• PU-cuffed ETT, conical
shape (SealGuard, Covidien,
Dublin, Ireland)
• PVC-cuffed ETT, conical
shape (
TaperGuard, Covidien, Dublin,
Ireland)
• ID 7.5 or 8 mm
• Multicenter RCT, 4 study
arms
• PU cylindrical group (n = 123)
• PVC cylindrical group (n = 129)
• PU conical group (n = 153)
• PVC conical group (n = 129)
At study inclusion, no important
differences between groups
were observed
• 25–30 cmH2O
• Manually controlled
with manometer every 6 h
• Airway management
standardized across
study sites
• Primary endpoint: bacterial
colonization of the trachea
(103 CFU/ml) at days 1, 2, 3, 7
• Secondary endpoint: cumulative
VAP rate during ICU stay,
defined on basis of clinical,
biological and radiological
patterns [41]; bacterial cultures
sampled in all patients
suspected of having VAP and
confirmed if quantitative
culture was at least 104 CFU/ml
• No differences in tracheal colonization
(at >103, >104, >105, or >106 CFU/ml)
were observed 48 h postintubation
(p > 0.05, p value indicates difference
across 4 groups)
• VAP rate between PU cylindrical and
PVC cylindrical group not different
(resp. 17.1 % vs. 10.8 %; p = 0.202)
• VAP rate between PU conical and
PVC conical group not different
(respectively 16.3 % vs. 13.2 %; p = 0.505)
• No difference in VAP rate observed
when both PU groups and both
PVC groups were pooled (respectively
16.6 % vs. 12.0 %; p = 0.140)
Abbreviations: PU polyurethane, PVC polyvinyl chloride, RCT randomized controlled trial, GCS Glasgow Coma Scale, VC volume-controlled, VT tidal volume, PEEP positive end-expiratory pressure, ID internal diameter,
VAP ventilator-associated pneumonia, CDC Centers for Disease Control and Prevention, PaO2/FiO2 ratio of arterial oxygen partial pressure to fractional inspired oxygen
Study arms or other aspects of the study that have no relationship with the outcome of interest of this review are not included in the summary of the individual studies
Blot
et
al.CriticalCare
 (2016) 20:203 
Page
9
of
13
practice, albeit to smoothen the intubation maneuver in
the first place.
The viscosity of the test fluid is another issue in which
in vitro experiments might deviate from the clinical situ-
ation. All but one of the included in vitro studies used
(dyed) water to evaluate the sealing ability of the cuffs.
Li Bassi et al., however, used an oropharyngeal secretion
simulant [11]. In this investigation, PU-cuffed tubes
sealed more efficiently than PVC-cuffed tubes.
PEEP plays an important role in the risk of microas-
piration because the upward pressure that it exerts on
an ETT cuff enables better sealing capacities and thus
reduces microaspiration and pneumonia [12]. Dave et al.
[13] tested cuffed ETTs under various levels of positive
pressure ventilation, with either 5 or 10 cmH2O PEEP,
simulation of an endotracheal suction maneuver using a
closed suction catheter with variable suction pressure
(either −20000 or −30000 Pa), and variable duration of
suctioning (5–20 seconds). Significantly less fluid leakage
was observed among PU-cuffed tubes than in PVC-cuffed
tubes, regardless of PEEP or suctioning settings. Lucangelo
et al. demonstrated that PVC-cuffed ETTs leaked whether
exposed to PEEP or not, while PU-cuffed ETTs did not leak
under either circumstance [14]. Zanella et al. evaluated fluid
leakage according to various PEEP levels (0, 5, 10, and 15
cmH2O) [15]. The PU-cuffed tubes demonstrated minor
leakage in the absence of PEEP, while PVC-cuffed tubes
leaked at all PEEP levels except 15 cmH2O. Lau et al.
demonstrated that PU cuffs sealed better than PVC
cuffs when PEEP levels were varied, and the ventilator
was disconnected [8].
The target Pcuff for HVLP cuffs is 20–30 cmH2O, and
all studies used a Pcuff within this range. In clinical prac-
tice, however, and in the absence of an automated Pcuff
controller, the Pcuff is extremely variable due to some
technical conditions (positive pressure ventilation, N2O
ventilation, sedation, and neuromuscular blocking agents)
[16–18], environmental circumstances (high altitudes,
such as during helicopter transport) [19], and patient-
related factors (e.g., core temperature, changes in patient
positioning) [20–22]. For that reason, with some in vitro
experiments, researchers additionally evaluated fluid leak-
age in case of low (<20 cmH2O) and high (>30 cmH2O)
Pcuff [8, 11, 13, 23]. Overall, a higher Pcuff results in better
sealing efficacy. Li Bassi et al. controlled for various cuff
characteristics by means of multivariate analysis [11]. A
greater cuff outer diameter was protective against fluid
leakage in multivariate analysis, together with Pcuff and
cuff length. Of note, cuff material had no significant
impact in multivariate analysis, but it displayed a clear
advantage in favor of PU cuffs in univariate analyses.
A caution pertaining to the amount of time allotted to
observe leakage past the cuffs is warranted when interpret-
ing the results of the in vitro experiments. The observation
periods varied from 20 minutes [23], to 1 h [8, 14, 24, 25],
and to 24 h [15, 26, 27]. Although these studies included
observation periods that were sufficient to demonstrate
significant differences between PU- and PVC-cuffed ETTs,
it is critical to recognize that aspiration may occur in
patients who are ventilated longer than 24 h. Indeed,
exposure time is pivotal in device-associated infections
such as VAP [28, 29].
In vivo study
Li Bassi et al. conducted an investigation that included
29 pigs in which 7 different ETTs were tested [26]. Fluid
leakage, as indicated by methylene blue or fluorescence
microsphere detection, was compared between PU- and
PVC-cuffed ETTs residing in five and four pigs, respect-
ively. Leakage of methylene blue was not observed past
either cuff type, but the percentage of microspheres per
gram of tracheal secretion was lower in animals with PU
cuffs than in those with PVC cuffs. The lack of statistically
significant differences in leakage between the cuffs may be
attributable to the limited number of pigs (i.e., power) that
were compared.
Clinical studies
Table 3 summarizes the clinical studies that compare PU-
and PVC-cuffed ETTs. Three RCTs were identified that
involved 708 patients, comprising 363 patients with PU-
cuffed tubes and 345 with PVC-cuffed tubes [14, 30, 31].
The Jadad score indicated two high-quality trials [14, 30]
and one trial with higher risk of bias [31] (Additional
file 1). Lucangelo et al. measured microaspiration (leakage)
of blue dye over 12 h, as evidenced by bronchoscopic
evaluation [14]. One hour after PEEP removal, leakage be-
came evident in all patients intubated with PVC-cuffed
ETTs, but leakage was not observed in the PU group.
However, at the end of the observation period, 17 of 20
patients in the PU group experienced microaspiration.
This study demonstrates that, after PEEP is removed,
microaspiration is relatively delayed with use of PU-
cuffed tubes compared with its onset when ETTs with
PVC cuffs are used. The clinical relevance of this obser-
vation is particularly pertinent to patients undergoing
short-term intubation (e.g., surgical patients).
In the remaining two RCTs, the rate of early postoper-
ative pneumonia and VAP were the respective outcomes
of interest. Philippart et al. evaluated the risk of VAP
among patients intubated with either PU-cuffed or PVC-
cuffed ETTs [31]. The study included four different
arms: a cylindrical PU group, a conical PU group, a cy-
lindrical PVC group, and a conical PVC group. No dif-
ferences in VAP rates were observed among the groups.
Despite its multicenter and randomized design, however,
that study had limitations. First, the study was not blinded.
Second, randomization was not organized on an individual
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basis. Instead, the investigators predetermined clusters of
nine or ten consecutive patients stratified by study centers,
with each cluster being assigned to one of the study groups.
It was anticipated that inclusion in a single cluster would
cover a period of 4–6 weeks for which an appropriate num-
ber of ETTs were made available. This approach does not
completely rule out bias generated by natural fluctuations
in local epidemiology of nosocomial infection (e.g., out-
breaks). Third, throughout the study period, Pcuff was con-
trolled by a manual manometer every 6 h. As already
mentioned, Pcuff is easily affected by several conditions and
can as such be considered an uncontrolled factor poten-
tially affecting the study results.
Two nonrandomized clinical studies with low risk of
bias according to the Downs and Black tool [10] were
identified (Additional file 1). Nseir et al. prospectively
measured pepsin levels in tracheal aspirates to assess
microaspiration in 48 patients. Despite the relative small
study size, significantly less microaspiration was observed
among patients intubated with PU-cuffed tubes. Of note,
the observation period was limited to 24 h, thereby sug-
gesting a potential advantage for short-term intubated pa-
tients, whereas the clinical benefit for patients with
prolonged ventilation remained uncertain. This hypothesis
is supported by data reported by Poelaert et al. [30]. In
their high-risk cardiac surgical patients, the rate of early
postoperative pneumonia was significantly lower among
patients intubated with PU-cuffed tubes (23 % vs. 42 %;
p = 0.026). In that study, the average periods of intubation
and mechanical ventilation were 25 h and 19 h for pa-
tients in the PVC cuff and PU cuff groups, respectively
(p = 0.22). In a post hoc analysis, Poelaert et al. determined
that use of PU-cuffed ETTs in high-risk cardiac surgery
patients is protective against early postoperative pneumo-
nia in patients who are intubated for up to 16.6 h [29].
In another non-RCT, Miller et al. evaluated VAP rates
in five ICUs during two periods of 1 year (baseline and
intervention). In the baseline and intervention periods,
respectively, PVC- and PU-cuffed ETTs were used.
Thereafter, ICUs used PVC-cuffed ETTs and VAP rates
were monitored for a 3-month period. The authors
showed a favorable reduction in VAP rates following the
introduction of the PU-cuffed ETT; however, nonrando-
mized studies are prone to bias, such as natural trends
in local epidemiology of microbial ecology and nosocomial
infection [32]. In addition, a Hawthorne effect cannot be
excluded. The Hawthorne effect might have led to im-
proved adherence in universal precautions in infection
prevention (e.g., hand hygiene) or in more specific mea-
sures to avoid VAP (e.g., oral care), albeit that no changes
in infection prevention policy were advocated during the
study period.
The potential positive effect of a medical device to
prevent microaspiration might be completely eliminated
by the failure to control for adequate Pcuff. No cuff seals
efficiently in the absence of a sufficiently inflated cuff. At
least three RCTs demonstrated that automated Pcuff
controllers are effective in keeping Pcuff levels within
the target range [33–35]. Therefore, it seems that auto-
mated Pcuff control is indispensable, regardless of the
cuff material. In addition, the value of automated Pcuff
controllers to avoid VAP was demonstrated in a recent
meta-analysis [36].
While PU cuffs do not totally succeed in avoiding
microaspiration, their advantage might strengthen other
features of ETTs to avoid leakage. Lorente et al. reported
the results of an RCT in which PU-cuffed tubes with
subglottic secretion drainage (SSD) were compared with
PVC-cuffed tubes without SSD [37]. The trial demon-
strated significantly reduced rates of early and late VAP in
the group of patients intubated with the PU-cuffed tube
(+SSD).
Limitations and future directions for research
This review has limitations. First, none of the clinical
studies addressed safety issues. While there are no particu-
lar concerns linked with the use of PU-cuffed tubes, con-
sidering long-term safety data may be a point of interest
in future studies. Second, the fact that tube characteristics
other than cuff material may play a role in sealing efficacy
is a limitation of this review. We could take into account
neither differences in cuff length nor discreet differences
in shape. Regarding the latter, we excluded comparisons of
PU vs. PVC cuffs when cuff shapes were tapered and/or
conical vs. cylindrical and/or globular in shape, as there
are in vitro and clinical data demonstrating improved
sealing capacity with taper-shaped cuffs [24, 38]. Finally,
among the included studies, there appeared to be substan-
tial differences in study designs, experimental setups, and
endpoints. As such, it appeared very difficult to make a
pooled estimate of the collected scientific evidence.
More clinical studies on the topic are welcome. RCTs
with optimal control for confounding factors should be
performed to further assess the value of PU-cuffed ETTs
in the prevention of VAP. Special emphasis should be
placed on identifying patients who might benefit the
most from PU-cuffed ETTs to reduce VAP risk. Concern-
ing early postoperative pneumonia, it may be worthwhile
to focus on oncology patients, such as those with esopha-
geal cancer undergoing esophagectomy, as these patients
have a particularly high risk for developing postoperative
pneumonia [39].
Conclusions
The in vitro, in vivo, and clinical studies reviewed here
provide evidence that, compared with PVC-cuffed tubes,
PU-cuffed tubes protect more efficiently against micro-
aspiration, or at least postpone substantial leakage of
Blot et al. Critical Care  (2016) 20:203 Page 11 of 13
secretions. Indeed, all studies reviewed here that had leak-
age and/or microaspiration as the primary outcome dem-
onstrated significant results [8, 11, 13–15, 23–25, 27, 40]
or at least a tendency toward more efficient sealing [26] in
association with PU cuffs. It should be mentioned that
only two (single-center) clinical studies assessed microas-
piration, including only one RCT. In particular, high-risk
patients intubated for shorter periods seemed to benefit
from the more effective sealing capacity of PU cuffs, as
such patients experienced a lower risk of early postopera-
tive pneumonia [30]. The evidence that PU-cuffed ETTs
prevent VAP is less robust, because microaspiration is
probably postponed rather than totally eliminated with
use of PU cuffs. As such, current evidence can support the
use of PU-cuffed ETTs in high-risk surgical patients, while
there is currently only very limited evidence that PU cuffs
prevent pneumonia in patients ventilated for prolonged
periods.
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